sumMARY The incidence of multiple sclerosis was shown to be 8-2/105/year (definite or probable 5 4 and suspected 2 8/105/year) during a 3 year prospective study carried out in an area of south east Wales which has a high prevalence ofthe disease (I 20/ 105). Mortality in affected individuals who were prevalent at the start of the survey was 3 1/105/year; many deaths resulted from direct complications ofmultiple sclerosis but 38% were due to unrelated causes. The rate at which new cases were identified approximately matched deletions from the register arising from death, outward migration and other causes so that prevalence did not change significantly during the survey (1985)(1986)(1987)(1988).
Statistics relating to the frequency and distribution of multiple sclerosis have been used both in planning the provision of services and in seeking to understand the cause of the disease. Regional variations in prevalence and alterations in the number ofcases identified in any one area with time have repeatedly been documented;' these may reflect true alterations in the frequency of multiple sclerosis but also could have arisen from variations in clinical vigilance and changes in the application of criteria used for classification and diagnosis. The most reliable statistics from which to make comparisons on regional or temporal variations in disease frequency are the rates for incidence and mortality; these can best be determined prospectively in an area where prevalent cases have already been identified. The prevalence of multiple sclerosis was documented in south east Wales on 1 January 1985;2 the incidence and mortality is now reported for the same area in the triennium [1985] [1986] [1987] [1988] .
Methods
A list of individuals, at one time living in south east Wales, in whom the diagnosis of multiple sclerosis had been made was compiled from the departmental diagnostic index (available from 1946) the Hospital Activity Analysis (available from 1967), information supplied by local general practitioners, membership lists of the local multiple sclerosis societies, and community services. The resources ofthe Family Practitioner were used to ascertain which of these individuals were no longer alive or had moved away from the study area. Based on personal interview or existing medical records the remainder were classified as having definite, probable or suspected multiple sclerosis on 1 January 1985, as previously reported.2
In the first survey, the year ofdiagnosis was recorded both for living and dead patients and this information was The incidence and mortality of multiple sclerosis in south east Wales 1/1 1/1 7/7 includes individuals with established multiple sclerosis who moved into the survey area, those in whom the presentation of pre-existing symptoms had been delayed for a variety of reasons, those in whom an alternative diagnosis had been revised, and patients whose symptoms developed for the first time during the period of study. Mortality was 3-1 x 105/year over the same period but if this figure is also adjusted to include all deletions from the register of cases prevalent in 1985, "incidence" and "mortality" are seen almost to be in equilibrium during the three year period.
These statistics need to be taken in the context of regional and temporal trends in the frequency of multiple sclerosis. Prevalence is the product of incidence or mortality and disease duration and will rise with an increase in any of these variables. The introduction of measures which influence survival from multiple sclerosis will have several effects on the frequency of the disease. An increased duration of disease arising from improved management of the complications will be followed by a rise in prevalence. Measures which rapidly alter survival, such as the introduction of antibiotics in the 1940s, will reduce annual mortality but this will increase with time as the cohort with improved survival succumbs to late complications of the disease or dies from unrelated causes. In the long term age specific mortality rates will alter, most deaths occurring in older patients, whereas mortality attributable to multiple sclerosis will be persistently reduced in the population of young adults who have the highest incidence of the disease. A significant alteration in age adjusted mortality from multiple sclerosis has in fact been observed in the United Kingdom over the last four decades.' An approximate measure of duration can therefore be obtained by comparing age specific rates for incidence and mortality. From a consideration of all these statistics it is likely that most of the reported temporal trends in prevalence have arisen entirely from increased duration of the disease.
Incidence is difficult to determine accurately since the interval between onset of symptoms and diagnosis is not constant and methods for identifying new cases or the application ofdiagnostic criteria and laboratory aids to diagnosis have changed with time. Errors occur even in the most careful of surveys. In our initial study 10/441 individuals were wrongly classified, clinically or demographically, and eight further cases were subsequently identified which should have appeared on the 1985 register. Surprisingly only three of 61 suspected cases were known to have developed further symptoms leading to reclassification as clinically definite or probable multiple sclerosis. This may be because we were not sufficiently rigorous in achieving follow up prior to the 1988 reclassification and the Hennessy, Swingler, Compston figure may represent an underestimate; alternative interpretations, apart from the possibility that the original episode was incorrectly diagnosed, are that these patients have demyelination in an isolated form which never recurs or benign multiple sclerosis in which relapses occur infrequently and subclinically. Prolonged follow up would be needed to resolve these issues. Alterations in mortality rate should also be interpreted with caution since patients with multiple sclerosis often die from unrelated causes and notification of contributory or coincidental conditions is omitted.
Rates for the incidence and mortality of multiple sclerosis need to be derived prospectively building upon a baseline register of prevalent cases. Reliable statistics depend upon prolonged epidemiological scrutiny in the survey area4" and relatively few studies are therefore available. However, it is of particular importance to have available serial estimates of incidence since if methodological artefacts have been eliminated, a change in rate strongly suggests an alteration in the biological factors favouring development of the disease. Comparisons of incidence and mortality are also important since disequilibrium, whether or not either rate has been serially determined over a prolonged period, also implicates a recent change in aetiological conditions. The importance of this type of analysis is seen in north east Scotland'4 in some parts of which both rates are reported to be falling9 following a prolonged period of high prevalence. 112
